HEPA

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Hepion Pharmaceuticals Inc

NASDAQ | HEPA

0.06

USD

$0.00

(

0.00%

)

At Close (As of Dec 11, 2025)

$766.94K

Market Cap

-

P/E Ratio

-46.06

EPS

$36.73

52 Week High

$0.10

52 Week Low

HEALTHCARE

Sector

HEPA Chart

Recent Chart
Price Action

HEPA Technicals

Tags:

HEPA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$31K
Total Revenue $0
Cost Of Revenue $31K
Costof Goods And Services Sold $31K
Operating Income -$19M
Selling General And Administrative $7.5M
Research And Development $12M
Operating Expenses $19M
Investment Income Net -
Net Interest Income -$1.2M
Interest Income -
Interest Expense $1.2M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -$1.9M
Income Before Tax -$16M
Income Tax Expense -$3M
Interest And Debt Expense -
Net Income From Continuing Operations -$13M
Comprehensive Income Net Of Tax -
Ebit -$17M
Ebitda -$19M
Net Income -$13M

Revenue & Profitability

Earnings Performance

HEPA Financials

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$18M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $31K
Capital Expenditures $3
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$600K
Cashflow From Financing $4.3M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$13M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$31K
Total Revenue $0
Cost Of Revenue $31K
Costof Goods And Services Sold $31K
Operating Income -$19M
Selling General And Administrative $7.5M
Research And Development $12M
Operating Expenses $19M
Investment Income Net -
Net Interest Income -$1.2M
Interest Income -
Interest Expense $1.2M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -$1.9M
Income Before Tax -$16M
Income Tax Expense -$3M
Interest And Debt Expense -
Net Income From Continuing Operations -$13M
Comprehensive Income Net Of Tax -
Ebit -$17M
Ebitda -$19M
Net Income -$13M

HEPA Profile

Hepion Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Edison, New Jersey, dedicated to developing innovative therapies for chronic liver diseases, with a particular focus on non-alcoholic steatohepatitis (NASH). The company is anchored by a strong pipeline and advanced drug discovery and development platforms that aim to meet significant unmet medical needs in hepatology. Its lead candidate, CRV431, shows substantial potential in treating liver conditions, positioning Hepion as a key player in the burgeoning market for liver therapeutics and highlighting its commitment to enhancing patient outcomes in this underserved space.

LPTX
+368.57%
$2.05
PAVS
+21.15%
$0.04
YCBD
+102.85%
$1.28
YGMZ
-61.42%
$0.02
OCG
+261.14%
$3.29
NVDA
-2.13%
$177.07
CGC
+46.02%
$1.65
WOK
-28.86%
$0.11
RIVN
+16.21%
$19.09
PLUG
+2.75%
$2.42
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
ATPC
-25.66%
$0.13
TSLA
+1.72%
$454.61
TLRY
+35.47%
$11.42
KAVL
-16.35%
$0.16
AVGO
-10.83%
$362.33
TNYA
-33.66%
$0.90
FRMI
-32.49%
$10.29
ADAP
-15.14%
$0.05
ZDGE
+20.57%
$2.93
ASST
-2.40%
$0.89
AKAN
+19.31%
$0.93
SOND
-23.45%
$0.12
ONDS
+0.56%
$9.07
VIVK
+0.40%
$0.07
INTC
-2.61%
$38.47
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SRM
+53.27%
$10.30
TE
-9.62%
$5.30
APLT
-45.50%
$0.11
SOFI
+1.14%
$27.38
PLTD
+1.90%
$6.44
WULF
-6.79%
$14.75
DNN
-5.80%
$2.59
PLTR
-1.09%
$185.48
IRBT
-10.63%
$4.46
BMNR
-5.75%
$36.17
MTSR
-0.35%
$70.50
RR
-8.65%
$4.27
ASBP
-7.84%
$0.09
MARA
-2.01%
$11.60
FI
+2.38%
$68.16
NFLX
+1.34%
$95.35
F
+1.02%
$13.76
VALE
-4.55%
$12.68
AFMD
-34.94%
$0.18
AAL
+0.90%
$15.09
RZLT
+9.32%
$1.53
CRWV
-8.46%
$79.97
KVUE
+0.02%
$17.32
RKLB
+0.29%
$63.72
IVP
-6.77%
$0.04
BITF
-5.95%
$2.76
CLSK
-2.64%
$14.42
AMD
-3.52%
$213.63
TWOH
0.00%
$0.00
GOOGL
-0.85%
$309.75
HOOD
-2.10%
$120.78
GRYP
-10.38%
$1.38
SNAP
-1.89%
$7.49
CAN
-6.61%
$0.86
BBD
+1.31%
$3.45
MODV
-25.22%
$0.43
KPLT
+20.87%
$7.50
CIFR
-6.54%
$17.64
GRAB
+0.77%
$5.22
SOUN
-0.46%
$11.97
CHR
-0.48%
$0.04
AMZN
-1.66%
$226.45
NIO
0.00%
$5.13
BTG
-1.82%
$4.59
WBD
+1.30%
$29.87
QBTS
-5.71%
$26.38
PFE
+0.66%
$25.97
HL
-3.85%
$18.60
ABEV
+1.40%
$2.53
ACHR
-3.79%
$8.23
NXDR
-9.11%
$2.51
RIG
-1.75%
$4.20
AG
-6.39%
$15.73
IBRX
+11.41%
$2.44
MU
-4.88%
$245.82
BAC
+1.07%
$55.14
CDE
-2.64%
$17.01
BYND
-3.34%
$1.14
RGTI
-6.54%
$25.12
AAPL
+0.19%
$278.57
SHOT
-74.37%
$0.39
LULU
+10.12%
$205.93
APLD
-6.47%
$28.76
ZAPP
-46.30%
$0.15
BTBT
-7.47%
$2.27
BLNK
-9.93%
$0.79
T
+1.50%
$24.66
PCG
+3.10%
$15.29
NCPL
+25.49%
$1.33
CRCG
-13.05%
$2.93
LPTX
+368.57%
$2.05
PAVS
+21.15%
$0.04
YCBD
+102.85%
$1.28
YGMZ
-61.42%
$0.02
OCG
+261.14%
$3.29
NVDA
-2.13%
$177.07
CGC
+46.02%
$1.65
WOK
-28.86%
$0.11
RIVN
+16.21%
$19.09
PLUG
+2.75%
$2.42
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
ATPC
-25.66%
$0.13
TSLA
+1.72%
$454.61
TLRY
+35.47%
$11.42
KAVL
-16.35%
$0.16
AVGO
-10.83%
$362.33
TNYA
-33.66%
$0.90
FRMI
-32.49%
$10.29
ADAP
-15.14%
$0.05
ZDGE
+20.57%
$2.93
ASST
-2.40%
$0.89
AKAN
+19.31%
$0.93
SOND
-23.45%
$0.12
ONDS
+0.56%
$9.07
VIVK
+0.40%
$0.07
INTC
-2.61%
$38.47
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SRM
+53.27%
$10.30
TE
-9.62%
$5.30
APLT
-45.50%
$0.11
SOFI
+1.14%
$27.38
PLTD
+1.90%
$6.44
WULF
-6.79%
$14.75
DNN
-5.80%
$2.59
PLTR
-1.09%
$185.48
IRBT
-10.63%
$4.46
BMNR
-5.75%
$36.17
MTSR
-0.35%
$70.50
RR
-8.65%
$4.27
ASBP
-7.84%
$0.09
MARA
-2.01%
$11.60
FI
+2.38%
$68.16
NFLX
+1.34%
$95.35
F
+1.02%
$13.76
VALE
-4.55%
$12.68
AFMD
-34.94%
$0.18
AAL
+0.90%
$15.09
RZLT
+9.32%
$1.53
CRWV
-8.46%
$79.97
KVUE
+0.02%
$17.32
RKLB
+0.29%
$63.72
IVP
-6.77%
$0.04
BITF
-5.95%
$2.76
CLSK
-2.64%
$14.42
AMD
-3.52%
$213.63
TWOH
0.00%
$0.00
GOOGL
-0.85%
$309.75
HOOD
-2.10%
$120.78
GRYP
-10.38%
$1.38
SNAP
-1.89%
$7.49
CAN
-6.61%
$0.86
BBD
+1.31%
$3.45
MODV
-25.22%
$0.43
KPLT
+20.87%
$7.50
CIFR
-6.54%
$17.64
GRAB
+0.77%
$5.22
SOUN
-0.46%
$11.97
CHR
-0.48%
$0.04
AMZN
-1.66%
$226.45
NIO
0.00%
$5.13
BTG
-1.82%
$4.59
WBD
+1.30%
$29.87
QBTS
-5.71%
$26.38
PFE
+0.66%
$25.97
HL
-3.85%
$18.60
ABEV
+1.40%
$2.53
ACHR
-3.79%
$8.23
NXDR
-9.11%
$2.51
RIG
-1.75%
$4.20
AG
-6.39%
$15.73
IBRX
+11.41%
$2.44
MU
-4.88%
$245.82
BAC
+1.07%
$55.14
CDE
-2.64%
$17.01
BYND
-3.34%
$1.14
RGTI
-6.54%
$25.12
AAPL
+0.19%
$278.57
SHOT
-74.37%
$0.39
LULU
+10.12%
$205.93
APLD
-6.47%
$28.76
ZAPP
-46.30%
$0.15
BTBT
-7.47%
$2.27
BLNK
-9.93%
$0.79
T
+1.50%
$24.66
PCG
+3.10%
$15.29
NCPL
+25.49%
$1.33
CRCG
-13.05%
$2.93
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.